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The stringent response is a stress signalling system mediated by the alarmones 14 
(pp)pGpp in response to nutrient deprivation. Research into the stringent 15 
response has exploded in recent years, with new insights highlighting the 16 
complexity and broad range of functions that these alarmones control. This review 17 
will provide an update on our current understanding of the enzymes involved in 18 
(pp)pGpp nucleotide turnover, including those shown to produce pGpp and its 19 
analogue (pp)pApp. Many studies to date have examined the impact of (p)ppGpp 20 
interacting with the RNAP to alter cellular processes. Here, we will describe a 21 
broader range of target pathways controlled by (pp)pGpp in the bacterial cell and 22 
the impact of this on multiple cellular processes, including DNA replication, 23 
transcription, nucleotide synthesis, ribosome biogenesis and function, as well as 24 
lipid metabolism. Finally, we will review the role of (p)ppGpp in bacterial 25 
pathogenesis, providing examples of how these nucleotides are involved in 26 
regulating many aspects of virulence and chronic infection. 27 
 28 
Bacteria encounter numerous environmental stresses during their lifecycle and need to 29 
respond quickly and efficiently in order to survive. There are several stress signalling 30 
pathways that enable bacterial adaptation, including some that rely on small nucleotide 31 
messengers. The stringent response is a ubiquitous stress signalling pathway that allows 32 
bacteria to respond to nutrient starvation1,2. During the stringent response, there is an 33 
accumulation of the alarmones guanosine tetra- (ppGpp) and pentaphosphate 34 
(pppGpp). These guanosine-based nucleotides are produced by members of the RSH 35 
(RelA/SpoT homologue) protein superfamily3 and are formed from GDP or GTP, 36 
respectively. More recently, the presence of a third member of this family, pGpp, has 37 
been confirmed in numerous species4-8. When discussing alarmone synthesis and 38 
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functions known to involve pGpp, we will refer to all three nucleotides as (pp)pGpp, 39 
otherwise (p)ppGpp will be used for ppGpp and pppGpp. (pp)pGpp have many 40 
intracellular targets including both protein and RNA molecules, allowing several 41 
aspects of bacterial metabolism and physiology to be activated or inhibited during the 42 
stringent response. Some (pp)pGpp-binding targets are common across the Bacteria, 43 
whereas others are specific to the lifestyle and niche of a species.  44 
As (pp)pGpp is such a widespread signalling nucleotide, it has been the focus of 45 
intense study in recent years. In this review, we discuss the latest advances in (pp)pGpp 46 
signalling. An update on our current understanding of the enzymes that synthesise and 47 
degrade all three alarmones, as well as the similar nucleotide (pp)pApp, is provided. 48 
We then highlight the broad range of metabolic pathways that (pp)pGpp regulates. This 49 
includes, but extends beyond, well-known interactions with the RNA polymerase 50 
(RNAP), to emphasise the importance of these alarmones in regulating diverse 51 
metabolic processes. (pp)pGpp is also an important player in bacterial pathogenicity. 52 
Here, we examine the contribution of these alarmones to virulence and chronic 53 
infection, using selected examples from different pathogens. Although a number of 54 
signals that trigger alarmone synthesis are referred to throughout, the mechanisms of 55 
how most of the stress signals are sensed by RSH enzymes have been comprehensively 56 
reviewed elsewhere9,10 and so will not be discussed in detail. 57 
 58 
Overview of (pp)pGpp synthesising enzymes 59 
The discovery of phosphorylated nucleotides is by no means recent, with both 60 
(p)ppGpp and (p)ppApp discovered over 50 years ago11-13. In the case of (p)ppGpp, 61 
work by Cashel and Gallant identified two unusual phosphorylated compounds after 62 
depriving Escherichia coli of amino acids11. These nucleotides controlled a decrease in 63 
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synthesis of stable RNAs such as tRNA and rRNA during starvation, commencing 64 
research into the stringent response. It is now well known that enzymes from the RSH 65 
superfamily are responsible for the synthesis and hydrolysis of (pp)pGpp3,4,14. Synthesis 66 
requires the transfer of a pyrophosphate (PPi) group from ATP to the 3′-OH group of 67 
the ribose moiety of GTP, GDP or GMP, achieved by nucleophilic attack of the β-68 
phosphate of ATP by the 3′-OH of GTP/GDP/GMP15 (FIG. 1a). RSH enzymes with 69 
catalytically active hydrolase (HD) domains are also able to hydrolyse (pp)pGpp by 70 
removing a PPi group to produce GTP/GDP/GMP16. The RSH superfamily is divided 71 
into three groups: long RSHs; small alarmone synthetases (SASs); and small alarmone 72 
hydrolases (SAHs)3.  73 
 74 
Long RSH enzymes 75 
The first RSH enzyme characterised was a long RSH termed RelA from E. coli, so 76 
named as relA mutant strains display a ‘relaxed’ phenotype, with stable RNA synthesis 77 
continuing in the absence of amino acids required for growth17. Long RSH proteins 78 
have now been identified from across the Bacteria, green algae and in plant 79 
chloroplasts3,14. These enzymes contain multiple domains divided between an 80 
enzymatic N-terminal region and a regulatory C-terminal region (FIG. 1b). The HD 81 
(Pfam accession PF13328) and synthetase domains (SYNTH: PF04607) comprise the 82 
enzymatic region. The SYNTH and HD domains work in concert to maintain an 83 
optimum level of (pp)pGpp depending on the environmental conditions18-20, with a 84 
functional HD domain required to avoid toxic accumulation of (pp)pGpp21. The switch 85 
between enzymatic activities is controlled by binding of the C-terminal region with 86 
interaction partners such as the starved ribosome22-26, as well as by substrate 87 
interactions27. Here, the binding of GDP and ATP to the SYNTH domain opens the 88 
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structure of the enzyme, activating synthetase activity and inhibiting hydrolase 89 
activity27. The binding of ppGpp to the HD domain, on the other hand, induces 90 
conformational changes that occlude the SYNTH domain and permit hydrolysis27. The 91 
identity of the domains present in the C-terminal region of long RSH proteins is 92 
described differently throughout the literature but generally are considered to comprise 93 
a TGS region (ThrRS, GTPase and SpoT: PF02824), a ZFD or CC domain (zinc finger 94 
domain/conserved cysteine), an alpha-helical domain and an ACT or RRM domain 95 
(aspartate kinase, chorismate and TyrA/RNA recognition motif: PF13291) (FIG. 1b). 96 
Using a Hidden Markov Model-based approach, 24,072 genomes were searched 97 
for RSH enzymes based on the presence of a SYNTH or a HD domain and classified 98 
into subfamilies based on phylogeny14. Long RSH enzymes were classified into 13 99 
different subfamilies, with most species possessing one long bifunctional enzyme, in 100 
addition to one other enzyme (monofunctional long RSH or SAS)3,14. E. coli, like most 101 
organisms in the Beta- and Gammaproteobacteria, contains two long RSH enzymes: 102 
the monofunctional RelA, which has a catalytically inactive pseudo-HD domain due to 103 
active site mutations; and the bifunctional enzyme SpoT28. Interestingly, the pseudo-104 
HD domain is structurally and evolutionarily conserved in the Beta- and 105 
Gammaproteobacteria, suggesting an additional role in stability or regulation of 106 
enzymatic activity3. Aside from the pseudo-HD domain in RelA, there are also 107 
differences in the catalytic sites of the SYNTH domains between RelA and SpoT from 108 
E. coli. RelA contains the acidic residues EFDD, whereas SpoT has basic residues 109 
RFKD29. This difference may be responsible for the preference of RelA for GDP and 110 
of SpoT for GTP as a substrate, as the motif is located near the GDP/GTP binding 111 
pocket30. It could also explain why SpoT has weaker synthetase activity than RelA31,32. 112 
E. coli also encodes a third enzyme involved in (p)ppGpp metabolism called GppA33 113 
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(FIG. 1a). Although it does not have a HD or SYNTH domain (and is therefore not a 114 
member of the RSH superfamily), it does convert pppGpp to ppGpp through its 115 
guanosine pentaphosphate phosphohydrolase activity so that ppGpp is the dominant 116 
nucleotide produced in E. coli33. Most bacteria outside of the Beta - and 117 
Gammaproteobacteria contain one bifunctional long RSH protein termed Rel, which 118 
can be accompanied by one or two SAS proteins3,14.  119 
Several interaction partners have been shown to regulate the enzymatic activity 120 
of long RSH proteins. For example, SpoT from E. coli interacts with the uncharged acyl 121 
carrier protein (ACP)34 and YtfK35 to respond to fatty acid starvation, as well as the E. 122 
coli 70-binding protein Rsd to sense carbon starvation36, while Rel/RelA proteins are 123 
regulated by stalled ribosomes37-39 (for recent reviews on regulation of synthetase 124 
activity see references9,10). The way in which Rel and RelA sense starved ribosomes 125 
has long been disputed, with theories suggesting that RelA from E. coli could ‘hop’ 126 
between different ribosomes to sense the charged status of tRNAs38 or that (p)ppGpp 127 
was produced following dissociation of active RelA from the ribosome40, as opposed 128 
to only when bound41. In recent years, much of how long RSH enzymes sense amino 129 
acid starvation was clarified, with publications of biochemical studies and a number of 130 
cryo-EM structures of RelA from E. coli in complex with the stalled ribosome22-25 (FIG. 131 
1c). When not bound to the ribosome, RelA/Rel enzymes adopt a closed conformation 132 
that favours (p)ppGpp hydrolysis25,42. Cryo-EM structures reveal that upon ribosome 133 
binding, RelA adopts an open conformation where (p)ppGpp synthesis is favoured23-25. 134 
Uncharged tRNA is not required for this initial RelA/Rel binding event, but it does 135 
stabilise the interaction and promotes synthesis22,25,26. When bound, the TGS, 136 
ACT/RRM and ZFD/CC domains of the C-terminal region of RelA interact with the A-137 
site finger element and the uncharged tRNA, while the enzymatic region extends away 138 
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from the ribosome producing (p)ppGpp23-26 (FIG. 1c). pppGpp can also allosterically 139 
bind to the N-terminal domain and positively influence its own synthesis, ensuring that 140 
production is fully induced in response to amino acid starvation22,43.  141 
 142 
Small alarmone synthetases 143 
SAS proteins only contain SYNTH domains and divide into 30 subfamilies spread 144 
across a diverse range of bacteria14. The best characterised of these are the RelP and 145 
RelQ families, which are found in the Firmicutes and share approximately 30% 146 
sequence identity10. Both RelP and RelQ lack regulatory sensory domains and 147 
expression is controlled at the transcriptional level, where alkaline shock44,45, ethanol 148 
stress46 and exposure to cell wall-targeting antibiotics44,47 can increase transcription (for 149 
recent reviews on regulation of synthetase activity see references9,10). Aside from RelP 150 
and RelQ, a number of additional SAS enzymes have now been characterised, such as 151 
RelV from the Proteobacterium Vibrio cholerae48, and RelS and RelZ from the actRel 152 
subgroup present in the Actinobacteria7. RelZ, is a unique SAS, in that it is the only 153 
RSH superfamily member characterised thus far that contains an additional enzymatic 154 
domain not involved in the metabolism of (pp)pGpp49. The enzyme, found in 155 
Mycobacterium smegmatis, has a SYNTH domain fused to an RNase HII domain that 156 
is involved in separating RNA-DNA hybrid structures termed R-loops, suggesting that 157 
(pp)pGpp has a role in resolving DNA damage49,50.  158 
 159 
Small alarmone hydrolases 160 
The presence of active HD-domain-containing SAH enzymes in bacteria was 161 
confirmed as recently as 201851 and 11 subfamilies have now been predicted based on 162 
phylogenetic analysis14. RelH from the Actinobacterium Corynebacterium glutamicum 163 
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is a member of the Mesh1-L (metazoan SpoT homologue-1 L) subgroup and is capable 164 
of hydrolysing (pp)pGpp in vitro, in an Mn2+ and pH-dependent manner51. An SAH 165 
protein called MESH1 is present in eukaryotes such as humans and Drosophila 166 
melanogaster, with both homologues able to hydrolyse (p)ppGpp and ppApp14,52. 167 
Mesh1-deficient Drosophila displayed slowed body growth and impaired revival upon 168 
amino acid depletion, suggesting a role in starvation responses52. However, these 169 
organisms do not appear to have homologues of (pp)pGpp synthetases52. Biochemical 170 
analysis has demonstrated that human MESH1 is instead, a cytosolic NADPH 171 
phosphatase that is able to cleave NADPH to NADH and inorganic phosphate to control 172 
cellular ferroptosis53. Structurally, NADPH has similarity to ppGpp, which together 173 
with the ability of MESH1 to degrade ppApp14, suggests that this enzyme has broad 174 
substrate specificity and is not specifically involved in alarmone signalling53. 175 
 176 
Expanding the nucleotide pool: pGpp and (pp)pApp  177 
pGpp 178 
Although first identified in Actinobacteria and Bacillus subtilis cells in response to 179 
amino acid starvation in the 1970s12,54, the characterisation of pGpp and its role in the 180 
stringent response is a topic of recent investigation. In 2015, the SAS RelQ from E. 181 
faecalis was shown to produce pGpp from GMP and ATP4, which could then be 182 
degraded by the HD domain of long RSH enzymes6. Like both pppGpp and ppGpp, 183 
pGpp from E. faecalis is capable of inhibiting enzymes involved in the GTP synthesis 184 
pathway (outlined below), as well as the transcription of rrnB by the E. coli RNAP, 185 
suggesting that it is a third nucleotide that functions in modulating the stringent 186 
response4. pGpp synthesis has now been detected from multiple long and short RSH 187 
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enzymes, including M. smegmatis6, Staphylococcus aureus5 and C. glutamicum7, as 188 
well as from RelA in E. coli30. 189 
 Interestingly, in B. subtilis and Bacillus anthracis cells, pGpp is also 190 
synthesised by the enzymatic degradation of pppGpp and ppGpp by a NuDiX 191 
(nucleoside diphosphate linked moiety X) hydrolase termed NahA8 (FIG. 1a). Here, 192 
NahA can hydrolyse between the 5′- and 5′- phosphate groups to produce pGpp both 193 
in vitro and in vivo. Similarly to (p)ppGpp, pGpp is capable of binding to a number of 194 
enzymes in the purine synthesis pathway, but unlike (p)ppGpp, does not interact with 195 
ribosome-associated GTPases8. NahA is not the only NuDiX hydrolase capable of 196 
cleaving (p)ppGpp, with MutT, NudG and RppH from E. coli55,56, and Ndx8 from 197 
Thermus thermophilis57, able to degrade (p)ppGpp to pGp. This highlights that the 198 




Phosphorylated purine molecules are not limited to guanosine variants. Enzymes 203 
capable of synthesising (p)ppApp have been identified in the actinomycetes12 and high 204 
levels of (p)ppApp accumulate in sporulating B. subtilis cells in a ribosome-dependent 205 
fashion13. A putative function for this nucleotide was identified in the 1970s, where 206 
ppApp was shown to positively affect transcription of rRNA in vitro, in contrast to the 207 
actions of (pp)pGpp58. In the last few years there has been a resurgence in interest in 208 
(p)ppApp. A crystal structure of ppApp in complex with the RNAP from E. coli has 209 
been solved, revealing that the nucleotide binds at a site distinct from the two (p)ppGpp 210 
binding sites that is near the catalytic centre59. This work also observed that in vitro 211 
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(p)ppApp functions in an opposite way to (pp)pGpp and activates transcription of rrn 212 
promoters by enhancing promoter binding and stabilising open complex formation59. 213 
Importantly, a number of RSH enzymes have now been shown capable of 214 
producing (pp)pApp in vivo. Of the 30 identified SAS subtypes, 5 are encoded in 215 
bicistronic toxin-antitoxin-like operons (toxSAS) that are widespread throughout the 216 
Bacteria14. While expression of members of the well-known RelP and RelQ groups in 217 
E. coli were nontoxic, expression of SAS enzymes from these 5 subfamilies inhibited 218 
cell growth unless co-expressed with their cognate antitoxin14. Inhibition of bacterial 219 
growth was mediated by the production of ppApp and ppGpp, and resulted in a 220 
downregulation of transcription, translation and DNA replication14. In each case, toxin 221 
activity could be controlled by the production of a proteinaceous antitoxin that binds to 222 
and inactivates the toxin, as for type II toxin-antitoxin systems. The activity of one 223 
tested toxin was also inhibited by a second antitoxin. This antitoxin had hydrolase 224 
activity (SAH) and cleaved the produced alarmones, similar to type IV toxin-antitoxin 225 
systems14.  226 
Pseudomonas aeruginosa encodes an enzyme that is structurally similar to RSH 227 
enzymes, however it cannot synthesise (p)ppGpp, instead producing (pp)pApp60. This 228 
enzyme, Tas1, acts as an interbacterial toxin, as it is injected by a type VI secretion 229 
system into neighbouring cells where it produces (pp)pApp60. The net result of this is a 230 
rapid depletion of cellular ATP, leading to wide-reaching rearrangements in metabolic 231 
processes. In addition, (pp)pApp is able to bind to (pp)pGpp target proteins such as 232 
PurF and directly inhibit purine biosynthesis60. Tas1 and toxSAS enzymes are by no 233 
means alone in their synthesis of alarmones as toxins. Genes encoding (p)ppGpp 234 
synthetases have been identified in a number of prophages, with suggested roles in viral 235 
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defence61-63. Here, (p)ppGpp is produced to shut down protein synthesis and arrest 236 
growth, thereby impeding lytic phage attack. 237 
It is interesting to note that unchecked production of (pp)pApp is toxic, just like 238 
unchecked production of (pp)pGpp in mutants without any hydrolase activity47. It may 239 
be that in addition to acting as a toxin, (pp)pApp is also a regulatory molecule and can 240 
positively influence transcription in certain species, as the in vitro data suggests58,59. 241 
This function would require the presence of a dedicated hydrolase and presumably a 242 
mechanism for controlling the rate of synthesis. As discussed above, there is a non-243 
toxic accumulation of (p)ppApp in sporulating B. subtilis cells13 and the role this plays 244 
in successful sporulation is unclear. Further research into regulation by (pp)pApp and 245 
its connection with the (pp)pGpp regulon will be essential for a complete view of 246 
nucleotide signalling in bacteria. 247 
 248 
Diverse metabolic pathways are controlled by (pp)pGpp 249 
The accumulation of (pp)pGpp via RSH enzymes has a diverse range of consequences 250 
in the cell by binding to a plethora of targets. Advances in binding-target identification 251 
techniques, including the use of DRaCALA-based interaction screens8,55,64 and 252 
biotinylated capture-compounds65, have revealed the widespread range of (pp)pGpp-253 
interacting targets. This diversity of function allows bacteria to respond to stress in 254 
different ways that are relevant to their life cycles or niches. Interestingly, there does 255 
not seem to be a consensus (pp)pGpp binding site shared by targets, with this nucleotide 256 
capable of interacting with members from varied protein families to both activate or 257 
inhibit enzyme function. This promiscuity may arise from a degree of conformational 258 
flexibility that (pp)pGpp possesses, where the 5′ and 3′ phosphate moieties can adopt 259 
either a ring-like or elongated conformation66.  260 
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 261 
DNA replication  262 
DnaG is a DNA primase that synthesises the RNA primers needed for DNA 263 
replication67. In E. coli and B. subtilis, the priming activity of DnaG is inhibited by 264 
direct binding of (p)ppGpp to the enzyme active site, reducing DNA replication68-70. 265 
Interestingly, ppGpp is a more potent inhibitor of DnaG in E. coli, whilst in B. subtilis 266 
pppGpp is the more potent inhibitor68,69. This may reflect the higher ratio of ppGpp to 267 
pppGpp in E. coli, while the opposite occurs in B. subtilis71-73. 268 
The stringent response is also responsible for decreasing the initiation of DNA 269 
replication in E. coli, with replication rates inversely correlated with ppGpp levels74,75. 270 
This is due, in part, to a reduction in the transcription of the replication initiation 271 
ATPase DnaA during the stringent response76, with expression of DnaA from a ppGpp-272 
insensitive promoter sufficient to overcome inhibition77. Interestingly, over-producing 273 
DnaA prior to (p)ppGpp accumulation does not rescue initiation78, whereas concurrent 274 
production does77, suggesting it is vital that DnaA is in the ATP-bound active state in 275 
order to compensate for the effects of (p)ppGpp. (p)ppGpp further impacts DNA 276 
replication by indirectly controlling the binding of DnaA to oriC via the lowering of 277 
negative supercoiling78. During normal growth, transcription induces negative 278 
supercoils in the oriC origin, thus promoting replication initiation79. When produced, 279 
(p)ppGpp binds to the RNAP and decreases cellular transcription, resulting in fewer 280 
negative supercoils near oriC, thereby decreasing the occupancy of DnaA78. It is 281 
currently unclear whether it is a general reduction in transcription or of specific key 282 
genes, for instance the DNA gyrase gene gyrA or topoisomerase IV, which acts to lower 283 
negative supercoiling78,80. However, the combined effect on negative supercoiling 284 
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together with the decrease in dnaA transcription, allows for more nuanced control of 285 
DNA replication. 286 
Control of DNA replication by (p)ppGpp is by no means limited to E. coli. In 287 
the Alphaproteobacterium Caulobacter crescentus, the differentiation of motile, 288 
scavenger swarmer cells into stalk cells requires the activation of DNA replication, 289 
which is inhibited in the swarmer cells81. This is reciprocally regulated by DnaA and 290 
the cell cycle transcriptional regulator CtrA, which controls promoter reprogramming 291 
during growth transitions82,83. The production of (p)ppGpp by this organism impacts 292 
cell cycle progression by activating the degradation of DnaA, stopping the synthesis of 293 
DnaA and inhibiting the proteolysis of CtrA84-86, all of which ensures that DNA 294 
replication does not occur. This prevents a premature switch from swarmer to stalk cell 295 
before the swarmer cell has found a nutrient rich environment. 296 
 297 
Nucleotide synthesis  298 
As (pp)pGpp accumulates in the cell, the GTP/GDP/GMP pools are lowered following 299 
substrate depletion87. However, it is now well established that (pp)pGpp also actively 300 
inhibits the synthesis of purine nucleotides88 (FIG. 2a), and that this regulation is 301 
essential for the survival of B. subtilis cells during starvation88,89. Here, synthesis begins 302 
with 5-phosphoribosyl-1-pyrophosphate (PRPP) leading to the production of inosine 303 
5′-monophosphate (IMP), which serves as the branch point between adenosine and 304 
guanosine nucleotide synthesis. In E. coli, both ppGpp and (p)ppApp can inhibit PurF, 305 
responsible for the first step in the conversion of PRPP to IMP, thus halting de novo 306 
biosynthesis of all purine nucleotides60,65. Two molecules of ppGpp bind to the PurF 307 
tetramer at an allosteric site, disrupting the formation of the catalytic centre and 308 
competitively inhibiting enzyme activity65 (FIG. 2b). (p)ppGpp can also inhibit the 309 
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ATP biosynthesis enzyme PurA, which converts IMP to adenylosuccinate8,65,90 (FIG. 310 
2a). Crystallisation of PurA soaked with ppGpp revealed guanosine 5′-diphosphate 311 
2′:3′-cyclic monophosphate (ppG2′:3′p) in the binding pocket (FIG. 2b), suggesting that 312 
the enzyme either has cyclase activity, or was able to extract the cyclic derivative from 313 
the soaking buffer91. The inhibition of these enzymes leads to a 65% decrease in ATP 314 
synthesis in the cell, a decrease which is balanced by less ATP being consumed in cells 315 
upon induction of the stringent response65. 316 
In addition to PurF, a number of enzymes specifically involved in the GTP 317 
biosynthetic pathway are targeted by (pp)pGpp (FIG. 2a), including the IMP 318 
dehydrogenase GuaB and the guanylate kinase Gmk8,88,92. GuaB is common to both the 319 
de novo and salvage nucleotide synthesis pathways and catalyses the formation of 320 
xanthosine monophosphate (XMP) from IMP, a reaction that is weakly inhibited by 321 
(p)ppGpp in B. subtilis88. In the same pathway, Gmk converts GMP to GDP, which is 322 
strongly inhibited by all three alarmones4,64,88. This inhibition is not conserved across 323 
bacteria however, as it does not occur in most Proteobacteria93,94. This is due to the lid 324 
domain of Gmk either being in a closed conformation (ppGpp insensitive – E. coli) or 325 
an open conformation (ppGpp sensitive – S. aureus) upon dimerisation of Gmk (FIG. 326 
2b)94,95.   327 
Components of the salvage nucleotide synthesis pathway are also inhibited by 328 
(pp)pGpp. Both HprT and XprT use PRPP as a phosphoribose donor to convert the 329 
purine bases hypoxanthine and guanine to IMP and GMP (HprT) or xanthine to XMP 330 
(XprT) (FIG. 2a)4,64,88,96. XprT is most potently inhibited by pGpp and ppGpp, which 331 
bind at the PRPP binding site (FIG. 2b) and protect cells from excess environmental 332 
xanthine96. The (pp)pGpp-bound form of HprT exists as an apo-tetramer (FIG. 2b), 333 
where it prevents dissociation of HprT into two active PRPP-bound dimers95. (pp)pGpp 334 
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binding not only competitively blocks the PRPP binding site but also the interaction at 335 
the dimer-dimer interface, which further potentiates (pp)pGpp inhibition95. Inhibition 336 
of HprT appears to be widespread across bacteria95, suggesting that the regulation of 337 
this enzyme by (pp)pGpp is important for GTP homeostasis as well as a stress response 338 
mechanism.  339 
Interestingly, PpnN, the enzyme which catalyses the reverse reactions to HprT 340 
and XprT is activated by (p)ppGpp (FIG. 2a)97. PpnN exists as a tetramer and ppGpp 341 
binds to allosteric sites at the monomer interfaces (FIG. 2b)55,97. This binding results in 342 
a conformational change that opens up the active site, thus increasing PpnN activity97 343 
and further directs metabolism away from GTP biosynthesis upon induction of the 344 
stringent response. 345 
 346 
Transcription 347 
One of the key consequences of (pp)pGpp accumulation during the stringent response 348 
is a change in transcriptional profile. There is general repression of rRNA synthesis and 349 
genes involved in metabolism of macromolecules such as DNA and phospholipids, 350 
with a concurrent increase in transcription of amino acid biosynthesis-encoding 351 
enzymes and nutrient transporters to overcome nutrient limitations. The transcriptional 352 
changes that occur during the stringent response are key to producing the slow growing 353 
phenotype characteristic of this response.  354 
In Alpha-, Beta-, Gamma-, Delta- and Epsilonproteobacteria, (p)ppGpp binds 355 
directly to RNAP to alter the transcription of genes both positively and negatively, with 356 
ppGpp being a more potent effector nucleotide than pppGpp94,98. There are two ppGpp 357 
binding sites on RNAP (FIG. 3a), and these are generally conserved across 358 
Proteobacteria99. Site 1 is found at the interface between the ω and β′ subunits100 (FIG. 359 
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3b, 3c). Site 2 is located at the interface between the β′ subunit and the transcription 360 
factor DksA101 (FIG. 3b, 3d), where the binding of ppGpp is thought to allosterically 361 
potentiate the inhibition of transcription by DksA102. The ability of RNAP from a given 362 
species to bind to (p)ppGpp at site 1 can be predicted by the presence of a MAR motif 363 
at the N-terminal end of the ω subunit103. The MAR motif is conserved in Alpha-, Beta-364 
, Gamma-, Deltaproteobacteria but is absent in other classes103. In E. coli, when 365 
(p)ppGpp binds to site 1, transcription is inhibited approximately 2-fold, whereas when 366 
both sites are bound, along with DksA, there is 20-fold inhibition101,104,105.  367 
A recent study has revealed the extent to which transcription is modulated upon 368 
activation of the stringent response in E. coli, with altered expression of 757 genes 5 369 
minutes, and 1224 genes 10 minutes after inducing expression of RelA from a 370 
plasmid106. Intriguingly, in an E. coli strain expressing a mutant RNAP that cannot bind 371 
to ppGpp, there were almost no changes in transcription following ppGpp 372 
accumulation106. This suggests that in E. coli, there are few, if any, genes that are 373 
regulated by ppGpp in an RNAP-independent manner. Comparing the transcriptional 374 
profiles through accumulation of ppGpp by recombinant expression of RelA106, rather 375 
than by nutritional limitation107, reveals large differences. 75% of the genes that are 376 
differentially expressed through recombinant expression of RelA are different to those 377 
seen upon stringent induction by serine hydroxamate106. This is likely due to metabolic 378 
changes or other stress responses being triggered during starvation conditions with 379 
confounding effects.  380 
In Firmicutes, Actinobacteria and Deinococcus-Thermus, (p)ppGpp does not 381 
interact with the RNAP94,108, and has no effect on the stability of the DNA-RNAP open 382 
complex. Therefore, any transcriptional changes observed during the stringent response 383 
are indirect108 or by (p)ppGpp interacting with riboswitches109 (BOX 1). During the 384 
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stringent response the level of GTP in the cell decreases due to its consumption in the 385 
production of pppGpp and through the direct inhibition of GTP biosynthesis enzymes 386 
by (pp)pGpp as described above8,21,88,95,96,108. This has an impact on transcription 387 
through two mechanisms. Firstly, in B. subtilis, σA-dependent promoters that are 388 
sensitive to iNTP levels and have a GTP as the initiating nucleotide at the +1 position, 389 
e.g. rRNA promoters, are transcribed at a lower frequency due to a slower initiation 390 
rate, while those that begin with an ATP tend to be upregulated108,110. Indeed, GTP 391 
nucleotides at positions +1 to +4 play a role in gene expression in S. aureus during the 392 
stringent response, suggesting that initial mRNA elongation is also sensitive to 393 
nucleotide levels in some species111. Secondly, GTP along with branched chain amino 394 
acids (BCAAs), are cofactors of the transcription repressor CodY, which is present in 395 
low G+C Gram-positive bacteria112. When GTP levels are low, CodY repression is 396 
relieved, allowing transcription of a variety of genes including those involved in amino 397 
acid biosynthesis and transport113. In S. aureus, 150 genes are upregulated when the 398 
stringent response is activated by leucine and valine starvation, with 143 of these 399 
increases due to CodY derepression114. On the other hand, 161 genes are downregulated 400 
independently of CodY, highlighting that CodY is an important factor for gene 401 
upregulation but not downregulation during the stringent response in S. aureus. 402 
 403 
Box 1: Riboswitches 404 
The repertoire of (p)ppGpp binding targets has now been expanded with the discovery 405 
that (p)ppGpp can target RNA molecules through interacting with riboswitches. 406 
Riboswitches are non-coding sections of mRNAs that bind to various ligands to allow 407 
regulation of gene expression. (p)ppGpp selectively binds to subtype 2a variants of the 408 
ykkC riboswitch, where it increases transcription of downstream genes109. Although not 409 
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widespread, this riboswitch is associated with BCAA biosynthesis and transporter 410 
genes, as well as ABC transporters and glutamate synthases and is mostly present in a 411 
subset of organisms within the Firmicutes109. Interestingly, ~40% of (p)ppGpp 412 
riboswitches in the 5′ untranslated region of BCAA biosynthesis genes are 413 
accompanied by a leucine T box RNA109. This element regulates gene expression by 414 
binding to uncharged leucine tRNA115. This suggests that when (p)ppGpp riboswitches 415 
and leucine T box RNA are found together, the presence of both (p)ppGpp and 416 
uncharged leucine tRNA is required for full gene expression109. This adds further 417 
complexity to the regulation of BCAA biosynthesis genes during the stringent response 418 
beyond CodY. Furthermore, there are no examples of a canonical CodY binding site 419 
consensus sequence116 upstream of a (p)ppGpp riboswitch, despite the fact that most 420 
species with (p)ppGpp riboswitches do have a codY gene, so the interplay between these 421 
regulatory mechanisms is unknown109. 422 
 423 
Ribosome maturation and function  424 
In addition to the effect on rRNA transcription, the stringent response also plays a role 425 
in inhibiting ribosome maturation and protein translation. Upon stringent response 426 
induction, it is generally accepted that mature ribosomes have a reduced rate of 427 
translation due to the inhibitory action of (p)ppGpp on several key enzymes (FIG. 4a). 428 
The initiation factor IF2 for instance, is inhibited by ppGpp, preventing the formation 429 
of the 30S initiation complex (30S IC), thus reducing translation117. However, 430 
translation of a subset of proteins is still required during the stringent response. Recent 431 
work indicates that 30S-bound IF2 has different tolerances for ppGpp depending on the 432 
mRNA present in the 30S pre-IC118 (FIG. 4b). Two consecutive hairpins known as a 433 
structured enhancer of translation initiation (SETI) next to the translation initiation 434 
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region mediate ppGpp tolerance for tufA and rnr mRNA (encoding elongation factor 435 
EF-Tu and RNase R, respectively) in E. coli118. Binding of SETI-containing mRNA to 436 
the pre-IC complexed with ppGpp allows for the exchange of ppGpp for GTP and the 437 
continuation of translation. pppGpp regulates translation slightly differently when 438 
bound to IF2, where it permits 30S IC formation in E. coli, but requires higher 439 
concentrations of IF2 to do so118. Whilst the utilisation of this mechanism throughout 440 
the Bacteria has yet to be demonstrated, in E. coli this allows permissive synthesis of a 441 
subset of proteins118. In addition to IF2, (p)ppGpp also acts to halt translation through 442 
inhibition of the elongation factors EF-Tu and EF-G (FIG. 4a), which are required for 443 
charged tRNA delivery and translocation of the peptide chain during synthesis119. 444 
During termination, RF3, which is required for recycling RF1 and RF2 from the 445 
ribosome, is inhibited by ppGpp120, whilst the inhibition of EF-G could also impact the  446 
recycling of the post-termination complex (FIG. 4a).  447 
In addition to halting translation, (p)ppGpp also inhibits active 70S formation 448 
in a number of ways. (p)ppGpp reduces mature 50S and 30S formation by inhibiting 449 
small GTPases involved in ribosome maturation64,121. Here, (p)ppGpp binds to the 450 
GTPases RsgA, RbgA, Era and Obg in a number of species8,55,64,122 and inhibits their 451 
GTPase activities64,122 as a way of reducing the 70S ribosome pool. Once formed, 452 
(p)ppGpp can also promote the sequestration of ribosomes. Overexpression of the 453 
synthetase RelP in a strain of B. subtilis that does not produce (p)ppGpp results in the 454 
formation of inactive 70S ribosome dimers termed 100S ribosomes, in a hibernation 455 
promoting factor (Hpf)-dependent manner123. (p)ppGpp also induces the transcription 456 
of hpf, rmf (ribosome modulation factor) and raiA (ribosome-associated inhibitor), all 457 
factors important for ribosome inactivation and dimerisation in E. coli124,125. As such, 458 
the stringent response controls 100S ribosome formation through transcriptional 459 
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regulation in multiple species123-125. Furthermore, the GTPase HflX in S. aureus can 460 
dissociate 100S ribosomes in a GTPase-dependent manner126. This activity is inhibited 461 
by (p)ppGpp, thus maintaining the inactive 100S ribosomes126. In E. coli, the 462 
transcription of hflX is under the control of a heat sensitive promoter127, implying that 463 
HflX functions during stress as a ribosome splitting factor and not in subunit 464 
maturation. However, it is unlikely that HflX is the main splitting factor in bacteria128 465 
and so it will be interesting to see if novel splitting factors are also regulated by 466 
(p)ppGpp. From all of the above, it is clear that (p)ppGpp can act to halt protein 467 
production at several key stages, ensuring slowed growth under stress. 468 
 469 
Lipid metabolism 470 
Fatty acid starvation is a well-known trigger of the stringent response129. (p)ppGpp 471 
production during fatty acid starvation inhibits many metabolic activities, ensuring that 472 
the cell volume does not outstrip the cell envelope capacity, thus maintaining the 473 
integrity of the envelope130. In E. coli, ACP is charged with a fatty acid chain during 474 
fatty acid biosynthesis. When fatty acid levels are low, an uncharged ACP binds to the 475 
TGS/RRM domain of SpoT, inducing (p)ppGpp production and thus triggering the 476 
stringent response34,131,132. (p)ppGpp synthesis by RelA is also triggered during fatty 477 
acid starvation, and to a greater extent than SpoT133. When fatty acid levels are low 478 
there is a reduction in cellular lysine, resulting in an accumulation of uncharged lysine 479 
tRNA that directly activates RelA133. This reduction in lysine is likely the result of a 480 
depletion of its precursor pyruvate, brought about during  fatty acid starvation133. The 481 
interaction between ACP and the long RSH does not occur with the Rel enzymes from 482 
B. subtilis or Streptococcus pneumoniae due to differences in the isoelectric points134. 483 
However, Rel from B. subtilis is still required for surviving fatty acid starvation, which 484 
 21 
may be more related to cellular GTP/ATP levels, rather than to production of 485 
(p)ppGpp130,135. It is possible that fatty acid starvation triggers the stringent response in 486 
the Firmicutes through depletion of lysine or other amino acids which use pyruvate as 487 
a precursor (such as valine, isoleucine and leucine) but this has not yet been 488 
investigated.  489 
A second protein that can trigger the stringent response during fatty acid or 490 
phosphate depletion is YtfK35. YtfK is a protein of unknown function present in 491 
Gammaproteobacteria, where it interacts with the N-terminal region of SpoT to trigger 492 
(p)ppGpp production and cell survival35. Internal imbalances in central metabolism can 493 
also trigger the stringent response. Repression of plsC, lptA and lpxA through CRISPRi 494 
results in (p)ppGpp accumulation in E. coli136. PlsC is involved in phospholipid 495 
biosynthesis, whilst lptA and lpxA encode key components of the outer membrane 496 
biogenesis pathway. Disrupting these aspects of lipid and cell envelope metabolism in 497 
a (p)ppGpp-null mutant causes unregulated growth and cell lysis136. Phospholipid 498 
metabolism is also regulated by (p)ppGpp binding to and inhibiting the enzymes 499 
responsible for the first and second steps of lipid and phospholipid biosynthesis (PlsB 500 
and PgsA, respectively)137,138.  501 
Additionally, (p)ppGpp inhibits the activity of several enzymes involved in the 502 
bacterial type-II fatty acid biosynthesis (FAS-II) pathway139. AccA and AccD are 503 
protein subunits of the heterotetrameric acetyl-CoA carboxytransferase which transfers 504 
a carbonyl group to acetyl-CoA, forming malonyl-CoA. The activity of the 505 
carboxytransferase complex (AccA2AccD2) is inhibited by (p)ppGpp139. Furthermore, 506 
FabA and FabZ, homologous β-hydroxyacyl-ACP dehydratases involved in fatty acid 507 
elongation, are inhibited by ppGpp at biologically significant levels140, highlighting that 508 
(p)ppGpp impacts lipid metabolism in multiple ways.  509 
 22 
 510 
Impact of the stringent response on bacterial pathogenicity  511 
The impact of the stringent response on virulence and pathogenesis is most commonly 512 
mediated through changes in transcriptional profile rather than through direct binding 513 
of (p)ppGpp to an effector protein. Even horizontally acquired virulence genes can be 514 
incorporated into the native stringent regulon, demonstrating the elasticity of the 515 
response141. While also impacting steady-state growth (BOX 2), the stringent response 516 
has been implicated in each stage of an infection, including adhesion, invasion, immune 517 
evasion, dissemination, biofilm formation and chronic infection, by many pathogens. 518 
While reviewed extensively by Dalebroux et al.,142,143, here we use examples from 519 
various pathogens, including E. coli, Salmonella species and S. aureus, to illustrate the 520 
role of the stringent response throughout an infection. 521 
 522 
Box 2: (p)ppGpp – indirect controller of steady-state growth rates in E. coli 523 
Altered cell growth is perhaps one of the most important aspects of bacterial survival 524 
and adaption to new environments. During the stringent response, (p)ppGpp is central 525 
to reorganising cellular processes, the effect of which is a reduction in growth2. Indeed, 526 
E. coli (p)ppGpp mutant strains lack growth rate control144, highlighting the important 527 
contribution (p)ppGpp makes to growth rate through its inhibition of numerous cellular 528 
processes, including DNA replication, ribosome synthesis and translation.  529 
During exponential growth of E. coli, the initiation of DNA replication 530 
increases, resulting in a high ori/ter ratio. In the absence of (p)ppGpp however, cells 531 
contain a constantly high ori/ter ratio despite changes in growth rate80, illustrating how 532 
(p)ppGpp-mediated inhibition of DNA replication can impact growth. The effects of 533 
(p)ppGpp on steady-state growth of E. coli were quantitatively explored by altering the 534 
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expression of either the RelA synthetase from E. coli or the Mesh1 hydrolase from D. 535 
melanogaster in amino acid-free minimal media145. Increasing (p)ppGpp levels during 536 
steady-state growth decreased the number of ribosomes in the cell, while lowering 537 
(p)ppGpp levels had the opposite affect145. A global resource allocation model146 was 538 
utilised, wherein the proteome was divided into three fractions: metabolic proteins and 539 
those constitutively expressed; ribosome-associated proteins; and growth rate-540 
independent proteins. This model revealed that increased levels of (p)ppGpp decreased 541 
growth by reducing ribosome-associated protein expression145. Interestingly, decreased 542 
amounts of (p)ppGpp also reduced growth as a result of lower expression of metabolic 543 
proteins. From this, it was apparent that (p)ppGpp indirectly impacts growth through 544 
finely balancing resource allocation to match the cellular growth rate.  545 
 546 
Adhesion 547 
As enterohemorrhagic E. coli (EHEC) moves from the nutrient-rich upper intestine to 548 
the nutrient-poor lower intestine, the expression of the horizontally-acquired locus of 549 
enterocyte effacement (LEE) pathogenicity island is triggered. This locus encodes 550 
factors involved in attachment and colonisation of the gut, including the type III 551 
secretion system (T3SS) and effector proteins needed for intimate adhesion147. In 552 
addition to a number of other transcriptional regulators, the expression of this locus is 553 
triggered by an accumulation of (p)ppGpp via RelA, resulting in an increase in 554 
adherence to epithelial cells during the stringent response141 (FIG. 5). Together with 555 
DksA, (p)ppGpp is essential for the activation of ler and pch transcription, two 556 
regulators required for the expression of the LEE regulon141. (p)ppGpp is also required 557 
for the downregulation of the flagella regulon in E. coli. Here, (p)ppGpp can inhibit the 558 
transcription of fhlDC, a master regulator of flagella synthesis genes106,148. 559 
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Fimbriae are crucial factors for bacterial attachment to host cells. The expression 560 
of type 1 fimbrial genes in uropathogenic E. coli (UPEC) is activated by (p)ppGpp 561 
through transcriptional activation of the fimB gene149. FimB is a recombinase that flips 562 
the promoter of the fimAICDFGH operon into the ‘on’ orientation, allowing 563 
transcription of these fimbriae-encoding genes. (p)ppGpp-null UPEC mutants display 564 
no fimbriae on their surface149. In contrast to this, mutants of the transcription factor 565 
dksA are hyperfimbriated, revealing that DksA and (p)ppGpp can function 566 
independently, as well as codependently150. Control of fimbriae expression by 567 
(p)ppGpp is also observed in Bordetella pertussis, where the expression of fim3, which 568 
encodes a subunit of the long filamentous structure, was decreased in a relA spoT 569 
double mutant151. 570 
 571 
Invasion  572 
During an infection, many bacterial species use the stringent response to aid in invading 573 
host tissues. A (p)ppGpp-null mutant of Salmonella enterica serovar Typhimurium 574 
shows reduced invasion of intestinal epithelial cells and is attenuated in the BALB/c 575 
mouse model (FIG. 5)152. The (p)ppGpp mutant strain had reduced expression of hilA 576 
and invF, two transcriptional activators of the Salmonella pathogenicity island 1 577 
(SPI1)152. SPI1 encodes a T3SS which secretes factors enabling bacterial uptake and 578 
invasion upon contact with specialised M cells in the intestinal epithelium153. 579 
Furthermore, the SlyA transcriptional activator in S. Typhimurium directly binds to 580 
(p)ppGpp, allowing the formation of SlyA dimers154. These dimers then bind to 581 
promoter DNA resulting in the transcription of many virulence genes154, such as pagC 582 
which encodes a membrane surface protein that aids survival in serum155.  583 
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The use of an iron overload murine model for S. Typhi infection revealed that 584 
mice infected with (p)ppGpp-null mutants were able to outlive their wild-type-infected 585 
counterparts, with decreased numbers of the mutant recovered from visceral organs, 586 
highlighting a role for (p)ppGpp in systemic infection156. (p)ppGpp was crucial for the 587 
production of flagella, with the null strain displaying decreased adhesion to, and uptake 588 
by, THP-1 phagocytes in vitro. (p)ppGpp mutants were reduced in their ability to 589 
invade epithelial cells, to survive in human serum and to survive within 590 
macrophages156. All of this ties in with observations from S. Typhimurium, where 591 
strains with C-terminal domain mutants of SpoT had defects in producing (p)ppGpp in 592 
response to acid stress, resulting in reduced metal cation uptake and reduced activation 593 
of SPI2 genes, producing an attenuated phenotype in a mouse model157. The 594 
requirement of (p)ppGpp for invasion of host cells is by no means limited to Salmonella 595 
species, with the stringent response important for the invasion and virulence of a 596 
number of intracellular pathogens, including Campylobacter jejuni158, Streptococcus 597 
suis159, Legionella pneumophila160 and E. faecalis161.  598 
 599 
Immune evasion and dissemination 600 
Many pathogens enter host cells during an infection in order to evade the immune 601 
system, requiring adaptation to a different environment. In S. aureus, the stringent 602 
response is induced following uptake by human polymorphonuclear neutrophils 603 
(PMNs), resulting in Rel-dependent induction of the cytotoxic phenol soluble modulins 604 
psm1-4 and psm1-2114. These cytotoxins lyse neutrophils and promote escape162,163, 605 
making the stringent response crucial for S. aureus survival after phagocytosis114 (FIG. 606 
5).  607 
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 Biofilms are complex communities of microorganisms held together by an 608 
extracellular matrix that can form on many different surfaces. This matrix enables 609 
resistance to opsonisation, complement deposition, phagocytosis by macrophages and 610 
ultimately immune evasion and subsequent bacterial dissemination164. A number of 611 
reports suggest a role for (p)ppGpp in regulating biofilm formation, however whether 612 
it is required for the formation or for the dispersal of biofilms appears to differ between 613 
species, with the precise mechanisms not yet fully understood. E. faecalis, for instance, 614 
can cause biofilm-mediated catheter-associated urinary tract infections (CAUTI), 615 
which are impacted by both (p)ppGpp and CodY165 (FIG. 5). (p)ppGpp-null and ΔcodY 616 
single mutants of E. faecalis show reduced biofilm formation and reduced colonisation 617 
of bladders and catheters in vivo165. However, the biofilm formation and colonisation 618 
of a (p)ppGpp-null ΔcodY double mutant was similar to wild-type, although this strain 619 
was unable to cause kidney infection, suggesting decreased virulence165. These findings 620 
agree with research in Listeria monocytogenes demonstrating that codY inactivation re-621 
establishes virulence to a certain extent in a (p)ppGpp mutant, as there is no repression 622 
of the CodY regulon (mimicking the stringent response)165,166. Biofilm formation is also 623 
regulated by the stringent response in species which do not encode codY, for example 624 
B. pertussis151, E. coli167 and Helicobacter pylori168.  625 
In contrast to the above examples, increased biofilm formation in the absence of 626 
a functional stringent response has been demonstrated in a number of species, including 627 
Porphorymonas gingivalis169 and Actinobacillus pleuropneumoniae170. In 628 
Pseudomonas putida, (p)ppGpp is required for biofilm dispersal by inhibiting the 629 
synthesis of the adhesin LapA, while simultaneously promoting its proteolysis171,172 630 
(FIG. 5). In S. epidermidis, the -PSMs are responsible for cell detachment and 631 
dissemination of cells from biofilms173, and as mentioned above, these toxins are 632 
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upregulated by (p)ppGpp in staphylococcal species114. These contradictions between 633 
species highlights the complexity and non-uniformity of the stringent response across 634 
bacteria, with much about how (p)ppGpp mechanistically controls biofilm formation 635 
and immune evasion remaining to be clarified. 636 
 637 
The role of (p)ppGpp in chronic infections 638 
Tolerance to cyclic antibiotics by a bacterial population has been found to enable the 639 
emergence of resistance174. These populations often contain small colony variants 640 
(SCVs), which are characterised as slow growing cells, with small colony sizes and 641 
mutations resulting in decreased virulence and metabolism175. In the laboratory, 642 
(p)ppGpp mutants are artificially generated in order to examine their effect on growth 643 
and virulence. However, an MRSA strain from a chronically infected patient harboured 644 
a mutation affecting (p)ppGpp production176. (p)ppGpp overexpression occurred due to 645 
a F128Y substitution in the hydrolase domain of Rel, constitutively activating the 646 
stringent response176. The transcription profile of the clinical isolate was similar to that 647 
of a strain in which the stringent response had been induced by the antibiotic mupirocin. 648 
This strain also had an upregulation of the global regulator-encoding agr locus, as well 649 
as substitutions in RpoB, in the DNA topoisomerase IV ParC and in the ribosomal 650 
methyltransferase RlmN, resulting in rifampicin, ciprofloxacin and linezolid 651 
resistance176. Notably, linezolid is a last resort antibiotic in the treatment of resistant 652 
infections. Altogether, these four mutations sequentially allowed the emergence of a 653 
resistant SCV within a chronic infection176. This is similar to findings by Mwangi and 654 
colleagues, who showed high levels of (p)ppGpp in a strain highly resistant to 655 
methicillin177 and demonstrates in a clinical environment how bacteria evolve to adapt 656 
to stressful conditions. 657 
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 658 
Conclusions and outlook 659 
In this review, we have examined some of the more recent discoveries relating to the 660 
synthesis and function of (pp)pGpp in bacteria. Although first identified many years 661 
ago, the recent characterisation of pGpp production and the use of (p)ppApp as a toxin, 662 
has stressed that there is still much to learn about these signalling systems. Excitingly, 663 
this also extends beyond the identification of new regulatory nucleotides, as an 664 
increasing number of pathways that are controlled by these nucleotides are being 665 
identified. Here, we have touched upon a number of metabolic processes that are 666 
regulated by (pp)pGpp, including priming for DNA replication, synchronising the 667 
production of both GTP and ATP to match cellular needs, controlling protein 668 
production at multiple points and adjusting fatty acid production. As discussed, all of 669 
the above processes are vital for bacterial survival in a host, explaining why these 670 
alarmones are intertwined with virulence and bacterial survival. 671 
The reallocation of cellular processes during times of stress is an incredibly 672 
complex process. Despite (p)ppGpp having been identified in the 1960s11, many 673 
unknowns about this signalling system remain. Until recently the vast majority of 674 
research had been conducted in E. coli. However, we now understand that while this 675 
system is ubiquitous throughout the Bacteria, the mechanisms of stress sensing, 676 
alarmone production and alarmone function are far more diverse than previously 677 
anticipated. Of the subfamilies of RSH enzymes identified3,14, only a small number 678 
have been characterised. Work to characterise the toxSAS subfamilies14 demonstrates 679 
that there may be functions for (pp)pGpp beyond the classical stringent response. 680 
Furthermore, other unidentified enzymes without SYNTH or HD domains involved in 681 
(pp)pGpp turnover may exist. Prime examples of this are the phosphohydrolase GppA33 682 
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or the NuDiX hydrolase NahA8. In addition, many other HD/SYNTH enzymes with 683 
functional domain fusions, like RelZ, could exist in order to adapt the stringent response 684 
to respond to stimuli specific for the survival of a given species. Extending from this, 685 
(pp)pGpp synthesis enzymes are present in the chloroplasts of plants and in green 686 
algae178-181, suggesting a fairly understudied role for these alarmones beyond the 687 
prokaryotes.  688 
New tools are continually being developed to aid our understanding of this 689 
signalling pathway. For example, the use of a DRaCALA (pp)pGpp binding screen in 690 
S. aureus64, E. coli55 and B. anthracis8, as well as the development of a (p)ppGpp 691 
capture-compound65 have significantly broadened the repertoire of (pp)pGpp targets. 692 
Combining that, with numerous “omic” techniques such as RNA-seq that provide 693 
interesting insights into processes controlled by (pp)pGpp106, has led to a much greater 694 
understanding of this system. These tools now need to be combined with in vivo work 695 
to fully explore how (pp)pGpp impacts bacterial pathogenicity. Much is still to be 696 
clarified on the role of (pp)pGpp in chronic infection, and the development of methods 697 
to detect the production of (pp)pGpp in vivo and monitor the triggers of the stringent 698 
response in host cells, will greatly improve our understanding of this essential 699 
signalling system in the future.  700 
  701 
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1197 
Figure 1. Synthesis and hydrolysis of (pp)pGpp by RSH enzymes. a) The synthetase 1198 
domain (SYNTH: grey) of RSH enzymes catalyses the transfer of a pyrophosphate 1199 
group from ATP to the ribose moiety of GTP/GDP/GMP to produce pppGpp, ppGpp 1200 
or pGpp, respectively. This reaction also generates a molecule of AMP. Conversely, 1201 
the hydrolase domain (HD: orange) is responsible for removing the pyrophosphate 1202 
group to recover GTP/GDP/GMP. Enzymes outside of the RSH superfamily are also 1203 
involved in (pp)pGpp metabolism, with GppA (pink) hydrolysing pppGpp to ppGpp33, 1204 
and NahA (blue) hydrolysing (p)ppGpp to pGpp8. b) Domain architecture and structure 1205 
of the long RSH enzyme RelA from E. coli (PDB: 5KPX), consisting of an N-terminal 1206 
domain (NTD) enzymatic region and a C-terminal domain (CTD) regulatory region. 1207 
 42 
The enzymatic region consists of the HD (orange – inactive in RelA) and SYNTH 1208 
(grey) domains. The regulatory region contains four domains: the TGS region (ThrRS, 1209 
GTPase and SpoT: red), an alpha-helical domain (tan), the ZFD/CC domain (zinc finger 1210 
domain/conserved cysteine: purple) and the ACT/RRM domain (aspartate kinase, 1211 
chorismate and TyrA/RNA recognition motif: green). c) Structure of RelA from E. coli 1212 
(orange) bound to the ribosome (PDB: 5L3P). An uncharged tRNA is located in the A-1213 
site (green) and P-tRNA in the P-site (grey). The 50S (blue) and 30S (yellow) subunits 1214 
of the ribosome are shown.  1215 
  1216 
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 1217 
Figure 2. (p)ppGpp-mediated inhibition of purine nucleotide synthesis. a) The first 1218 
step of de novo purine synthesis (yellow box) begins with 5-phosphoribosyl-1-1219 
pyrophosphate (PRPP) which is converted to 5-phosphoribosylamine (PRA) by PurF, 1220 
 44 
an amidophosphoribosyltransferase (blue). Through a complex series of reactions, PRA 1221 
is ultimately modified to inosine 5′-monophosphate (IMP), which is the precursor for 1222 
both ATP and GTP. The salvage pathway (pale red box) on the other hand, begins with 1223 
the conversion of purine bases such as hypoxanthine, xanthine and guanine to IMP, 1224 
xanthosine monophosphate (XMP) and guanosine monophosphate (GMP) respectively. 1225 
Conversions to IMP and GMP are catalysed by hypoxanthine 1226 
phosphoribosyltransferase (HprT: yellow), while XMP is formed by xanthine 1227 
phosphoribosyltransferase (XprT: pink), which all utilise PRPP as a phosphoribose 1228 
donor. Adenine is modified to AMP by adenine phosphoribosyltransferase (AprT) 1229 
(brown). PpnN, pyrimidine/purine nucleotide 5′-monophosphate nucleosidase (orange) 1230 
catalyses the reverse reaction using AMP, IMP, XMP and GMP as substrates. For GTP 1231 
synthesis, the IMP dehydrogenase GuaB (purple) converts IMP to XMP, which is 1232 
utilised by GuaA to form GMP. Guanylate kinase (Gmk: grey) converts GMP to GDP. 1233 
For ATP synthesis, the adenylosuccinate synthetase PurA (green) produces 1234 
adenylosuccinate (AMP-S) from IMP, which is a precursor for ATP. All enzyme names 1235 
written in red are inhibited by (pp)pGpp8,65,88,90,92,96, while those in green (PpnN) are 1236 
activated97. AprT, displayed as a fainter red, is weakly inhibited by (p)ppGpp in E. 1237 
coli55. b) Crystal structures of purine nucleotide synthesis enzymes shown in cartoon 1238 
representation in complex with ppGpp, pppGpp or ppG2′:3′p (spacefilled). Monomers 1239 
(PurA from E. coli – PDB: 1CH8 & PpnN from E. coli – PDB: 6GFM) are coloured 1240 
yellow. Dimers (Gmk from S. aureus – PDB: 4QRH & XprT from B. subtilis – PDB: 1241 
1Y0B) in yellow and blue, while tetramers (PurF from E. coli – PDB: 6CZF & HprT 1242 
from B. anthracis – PDB 6D9S) are coloured yellow, blue, pink and grey. Structures 1243 




Figure 3.  ppGpp binding to the RNAP. a) Schematic of the holoenzyme of RNAP 1247 
bound to two molecules of ppGpp (red) and DksA (yellow). Individual RNAP subunits 1248 
are coloured:  – purple, ′ – pink, I – teal, II - orange,  - green and 70 – brown. 1249 
b-d) Crystal structure of the RNAP holoenzyme from E. coli in complex with ppGpp, 1250 
DksA and the rrnBP1 promoter (PDB: 6WRD). Coloured as in (a). b) Face-on view of 1251 
the RNAP bound to the rrnBP1 DNA. c) Rotation of the RNAP 90º to visualise ppGpp 1252 
(red) bound to site 1 between the ′ (pink) and  (green) subunits. d) Rotation to 1253 




Figure 4. Control of protein translation by (p)ppGpp. a) (p)ppGpp directly binds to 1257 
and inhibits a number of proteins responsible for the different stages of translation. 1258 
Through association with GTP, the prokaryotic initiation factor IF2 acts to position the 1259 
initiating fMet-tRNAfMet in the 30S pre-IC and promote the association of the 50S 1260 
subunit, a process which is inhibited by (p)ppGpp117,118. Elongation and translocation 1261 
processes are also targets of (p)ppGpp. (p)ppGpp-mediated inhibition of the elongation 1262 
factor EF-Tu prevents the binding of an aminoacyl-tRNA to the A site of the 70S 1263 
 47 
ribosome119. Inhibiting EF-G, a translocase, stops the translocation of aminoacyl-tRNA 1264 
through the ribosome119. (p)ppGpp also inhibits the release factor RF3, therefore 1265 
preventing the recycling of RF1/2 from the ribosome120. The post-termination complex 1266 
is recycled by RRF and EF-G, allowing the cycle to start again, a process that may also 1267 
be inhibited by (p)ppGpp interacting with EF-G. b) ppGpp binding to IF2 inhibits start 1268 
codon recognition. The pre-IC can then exchange a non-compatible transcript for one 1269 
that contains a structured enhancer of translation initiation (SETI) element that is 1270 
tolerated by ppGpp e.g. tufA, allowing the exchange of ppGpp for GTP and the 1271 
continuation of translation118.  1272 
 1273 
  1274 
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1275 
Figure 5. (p)ppGpp affects bacterial pathogenicity in multiple ways. (p)ppGpp (red 1276 
star) can regulate genes to promote pathogenicity, including the downregulation of 1277 
flagella and the upregulation of surface proteins and factors that promote increased 1278 
attachment to host cell surfaces141,147-150. (p)ppGpp can promote invasion into host cells 1279 
by upregulating toxins and pathogenicity islands, and avoidance of cellular defences by 1280 
controlling the production of cytolytic toxins152,153,155. (p)ppGpp also has a role to play 1281 
in immune evasion and bacterial dissemination via toxin production114,162 and the 1282 
regulation of biofilm formation. Both (p)ppGpp and the transcription factor CodY have 1283 
been implicated in the formation of biofilms165,166,168, while the promotion of biofilm 1284 
dispersion through various (p)ppGpp-mediated mechanisms has also been reported170-1285 
172. 1286 
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